mail
editor@ajptr.com
whatsapp
9409046853
logo

American Journal of PharmTech Research

Ehsan Rauf

Author Profile
Research Associate (Unani), Central Research Institute of Unani Medicine, Lucknow, UP, India.
2
Publications
2
Years Active
2
Collaborators
60
Citations

Publications by Ehsan Rauf

2 publications found • Active 2014-2016

2016

1 publication

Therapeutic Evaluation of Habb-E-Suranjan In Hyperuricemia

with M.Mohsin, Tabassum Latafat
12/1/2016

The concept of hyperuricemia has not been described at all in Unani system of medicine, but description of a joint disorder known as Niqris, has been found in most of the classical Unani texts. The clinical features of Niqris very much resemble with the Gout as described in Allopathy, which occurs due to hyperuricemia. In practice, hyperuricemia is frequently defined as a serum urate levels exceeding of 7mg/dl (0.42 mmol/l) in adult males and 6 mg/dl (0.36 mmol/l) in adult females. However, this arbitrary definition of Hyperuricemia has been justified by epidemiological studies showing that those with SUA levels greater than 7mg/dl are at increased risk of developing gouty arthritis and urolithiasis. Hyperuricemia is fairly common, with a prevalence ranging between 2.3 to 41.4 percent in various populations. A variety of factors appear to be associated with higher serum urate concenterations. The present study was conducted on 50 patients of Primary Hyperuricemia attending the OPD of Ajmal Khan Tibbiya College and Hospital. During the study it was observed that the mean serum uric acid level, which was 8.6±1.1before the beginning of the study got reduced to 6.6±1.3 at the end of the study. As we applied paired “t” test to the observations recorded before and after treatment it was found that t=12.6, p

2014

1 publication

Aatrilal (Ammi majus Linn): A Potent Drug For Vitiligo

2/1/2014

Aatrilal (Ammi majus Linn) is an important unani drug for treatment of vitiligo. It belongs to family Apiaceae. It is originated in Egypt. But now it is successfully cultivated in India. It is the principal commercial source of Xanthotoxin. Xanthotoxin is used in the treatment of Vitiligo (Leucoderma).It is also used as diuretic, blood purifier, detergent, emmenogogue, and has antispasmodic and anti inflammatory properties. In Unani system of Medicine Aatrilal is used both internally as well as externally in the patients of Bars (Vitiligo). A number of clinical studies have been carried out with the Aatrilal in the treatment of vitiligo. These trials have shown significant results.

Author Statistics
Total Publications:2
Years Active:2
First Publication:2014
Latest Publication:2016
Collaborators:2
Citations:60
Whatsapp